Davenport & CO LLC Mei Pharma, Inc. Transaction History

Davenport & CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$2.73 - $4.5 $240,240 - $396,000	-88,000 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$2.6 - $3.32 $94,640 - $120,848	36,400 Added 70.54%	88,000 $232,000
Q3 2020 Oct 15, 2020	BUY	$2.46 - $4.27 $26,076 - $45,261	10,600 Added 25.85%	51,600 $161,000
Q2 2020 Jul 28, 2020	BUY	$1.45 - $4.3 $1,450 - $4,300	1,000 Added 2.5%	41,000 $169,000
Q1 2020 May 05, 2020	SELL	$0.75 - $2.55 $10,500 - $35,700	-14,000 Reduced 25.93%	40,000 $64,000
Q4 2019 Jan 22, 2020	BUY	$1.65 - $2.48 $89,100 - $133,920	54,000 New	54,000 $134,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.